Published in Cochrane Database Syst Rev on July 16, 2008
Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell (2015) 3.13
Gut microbiota and inflammation. Nutrients (2011) 1.60
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol (2012) 1.19
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol (2014) 1.01
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol (2014) 0.87
Probiotics in inflammatory bowel diseases and associated conditions. Nutrients (2011) 0.85
Association of gut microbiota with post-operative clinical course in Crohn's disease. BMC Gastroenterol (2013) 0.83
Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Curr Nutr Food Sci (2013) 0.83
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol (2014) 0.82
Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS One (2014) 0.80
Diet therapy for inflammatory bowel diseases: The established and the new. World J Gastroenterol (2016) 0.80
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches. Curr Treat Options Gastroenterol (2015) 0.79
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol (2016) 0.78
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
Clinical Uses of Probiotics. Medicine (Baltimore) (2016) 0.76
Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis. PLoS One (2016) 0.75
Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration. Nutrition (2017) 0.75
Gastrostomy tube feeding in children with cerebral palsy: a prospective, longitudinal study. Dev Med Child Neurol (2005) 1.64
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review). Evid Based Child Health (2013) 1.42
Impact of gastrostomy tube feeding on the quality of life of carers of children with cerebral palsy. Dev Med Child Neurol (2004) 1.09
Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev (2011) 1.00
Inverted appendix mistaken for a polyp during colonoscopy and leading to intussusception. J Cyst Fibros (2005) 0.99
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev (2011) 0.86
Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev (2012) 0.85
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.83
Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease. Clin Nutr (2006) 0.79
Quality of life in paediatric gastrointestinal and liver disease: a systematic review. J Pediatr Gastroenterol Nutr (2007) 0.77
Gastrostomy feeding versus oral feeding alone for children with cerebral palsy. Cochrane Database Syst Rev (2013) 0.76
Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease. J Pediatr Gastroenterol Nutr (2010) 0.76
Pilot evaluation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2008) 0.76
Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev (2016) 0.75